209 related articles for article (PubMed ID: 35250847)
21. A New Perspective for Predicting the Therapeutic Success of RFA in Solid BTNs: Quantitative Initial RFA Ratio by Contrast-Enhanced Ultrasound.
Zhu Y; Jiao Z; Zhu L; Xie F; Song Q; Yan L; Luo Y; Zhang M
Front Endocrinol (Lausanne); 2022; 13():904459. PubMed ID: 35774147
[TBL] [Abstract][Full Text] [Related]
22. Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomized, Parallel, Open-Label, Trial (LARA Trial).
Cesareo R; Pacella CM; Pasqualini V; Campagna G; Iozzino M; Gallo A; Lauria Pantano A; Cianni R; Pedone C; Pozzilli P; Taffon C; Crescenzi A; Manfrini S; Palermo A
Thyroid; 2020 Jun; 30(6):847-856. PubMed ID: 32056501
[No Abstract] [Full Text] [Related]
23. Ultrasound-guided radiofrequency ablation (RFA) of benign symptomatic thyroid nodules - initial UK experience.
Jawad S; Morley S; Otero S; Beale T; Bandula S
Br J Radiol; 2019 Jun; 92(1098):20190026. PubMed ID: 31084496
[TBL] [Abstract][Full Text] [Related]
24. Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound.
Yan L; Luo Y; Xiao J; Lin L
Eur Radiol; 2021 May; 31(5):3226-3236. PubMed ID: 33128600
[TBL] [Abstract][Full Text] [Related]
25. Successful radiofrequency ablation strategies for benign thyroid nodules.
Lee GM; You JY; Kim HY; Chai YJ; Kim HK; Dionigi G; Tufano RP
Endocrine; 2019 May; 64(2):316-321. PubMed ID: 30569260
[TBL] [Abstract][Full Text] [Related]
26. Neural monitoring during ultrasound-guided radiofrequency ablation of thyroid nodules.
Lin E; Lin S; Fu J; Lin F; Luo Y; Hong X; Chai B; Liang K; Wu G
Int J Hyperthermia; 2020; 37(1):1229-1237. PubMed ID: 33131338
[TBL] [Abstract][Full Text] [Related]
27. Can Thyroid Nodules be Managed with Radiofrequency Ablation?
Kandil E; Issa PP; Randolph GW
Adv Surg; 2023 Sep; 57(1):87-101. PubMed ID: 37536864
[TBL] [Abstract][Full Text] [Related]
28. Twelve-Month Volume Reduction Ratio Predicts Regrowth and Time to Regrowth in Thyroid Nodules Submitted to Laser Ablation: A 5-Year Follow-Up Retrospective Study.
Negro R; Greco G; Deandrea M; Rucco M; Trimboli P
Korean J Radiol; 2020 Jun; 21(6):764-772. PubMed ID: 32410415
[TBL] [Abstract][Full Text] [Related]
29. Contrast-enhanced ultrasound is a reliable and reproducible assessment of necrotic ablated volume after radiofrequency ablation for benign thyroid nodules: a retrospective study.
Yan L; Li X; Xiao J; Li Y; Zhu Y; He H; Luo Y
Int J Hyperthermia; 2022; 39(1):40-47. PubMed ID: 34936850
[TBL] [Abstract][Full Text] [Related]
30. Nomogram prediction for the involution of the ablation zone after radiofrequency ablation treatment in patients with low-risk papillary thyroid carcinoma.
He H; Zhang Y; Song Q; Zhao J; Li W; Li Y; Luo Y
Int J Hyperthermia; 2021; 38(1):1133-1139. PubMed ID: 34348562
[TBL] [Abstract][Full Text] [Related]
31. Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study.
Yan L; Luo Y; Zhang M; Xiao J
Int J Hyperthermia; 2020; 37(1):777-785. PubMed ID: 32619366
[No Abstract] [Full Text] [Related]
32. Single-session treatment of benign thyroid nodules with radiofrequency ablation: Results at 6 months in 24 patients.
Familiar Casado C; Merino Menendez S; Ganado Diaz T; Pallarés Gasulla R; Pazos Guerra M; Marcuello Foncillas C; Calle Pascual A
Endocrinol Diabetes Nutr (Engl Ed); 2020 Mar; 67(3):164-171. PubMed ID: 31439500
[TBL] [Abstract][Full Text] [Related]
33. Radiofrequency Thermal Ablation of Benign Thyroid Nodules: The Correlation Between Ultrasound Nodule Characteristics and Results.
Feroci F; Guagni T; Coppola A; Perini D; Conforti B; Genzano C; Belliti D; Petrucci A; Sarno A; Cantafio S
Surg Innov; 2020 Aug; 27(4):342-351. PubMed ID: 32238104
[No Abstract] [Full Text] [Related]
34. Long-Term Efficacy of a Single Session of RFA for Benign Thyroid Nodules: A Longitudinal 5-Year Observational Study.
Deandrea M; Trimboli P; Garino F; Mormile A; Magliona G; Ramunni MJ; Giovanella L; Limone PP
J Clin Endocrinol Metab; 2019 Sep; 104(9):3751-3756. PubMed ID: 30860579
[TBL] [Abstract][Full Text] [Related]
35. Comparison between microwave ablation and bipolar radiofrequency ablation in benign thyroid nodules: differences in energy transmission, duration of application and applied shots.
Vorländer C; David Kohlhase K; Korkusuz Y; Erbelding C; Luboldt W; Baser I; Korkusuz H
Int J Hyperthermia; 2018; 35(1):216-225. PubMed ID: 30300014
[TBL] [Abstract][Full Text] [Related]
36. Thyroid Nodule Radiofrequency Ablation: Complications and Clinical Follow Up.
Lim JY; Kuo JH
Tech Vasc Interv Radiol; 2022 Jun; 25(2):100824. PubMed ID: 35551808
[TBL] [Abstract][Full Text] [Related]
37. Analysis of 5 years' experience of a head and neck surgeon with radiofrequency ablation for benign thyroid nodule.
Lee MK; Lee SW
Am J Otolaryngol; 2023; 44(2):103715. PubMed ID: 36473260
[TBL] [Abstract][Full Text] [Related]
38. Efficacy in size and symptom reduction of radiofrequency ablation of benign non-functioning thyroid nodules.
Rodriguez Escobedo R; Martinez Tames G; Lanes Iglesias S; Alonso Felgueroso C; Montes Garcia AM; Prieto Fernandez A; Sanchez Ragnarsson C; Menendez Torre EL
Endocrinol Diabetes Nutr (Engl Ed); 2022 Mar; 69(3):194-200. PubMed ID: 35396117
[TBL] [Abstract][Full Text] [Related]
39. Risk factors of recurrent thyroid nodules after radiofrequency ablation.
Xia Y; Fu Y; Qian M; Cui Y
Afr Health Sci; 2023 Sep; 23(3):584-592. PubMed ID: 38357154
[TBL] [Abstract][Full Text] [Related]
40. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients.
Jeong WK; Baek JH; Rhim H; Kim YS; Kwak MS; Jeong HJ; Lee D
Eur Radiol; 2008 Jun; 18(6):1244-50. PubMed ID: 18286289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
